Dr Reddy’s Laboratories is currently trading at Rs 1277.70, up by 30.15 points or 2.42% from its previous closing of Rs 1247.55 on the BSE. The scrip opened…
Dr. Reddy’s Laboratories is currently trading at Rs. 5551.05, up by 74.55 points or 1.36% from its previous closing of Rs. 5476.50…
Dr. Reddy’s Laboratories’ wholly owned subsidiary — Aurigene Discovery Technologies (Aurigene) and Olema Pharmaceuticals, Inc (Olema) have entered into exclusive global license…
Dr. Reddy’s Laboratories has launched Sevelamer Carbonate for Oral Suspension, in 0.8 g and 2.4 g packets, a therapeutic equivalent generic version…
The US Food and Drug Administration (USFDA) has completed the audit of Dr. Reddy’s Laboratories’ Formulations Srikakulum Plant (SEZ) Unit II, Andhra…
